RE: Patients, Patience + Patents30 Nov 2022 11:04
Happy to show my ignorance if someone can enlighten me to the answer..
PK data will have to be garnered from biopsy material, I think. And we are talking of near to end of life patients who've been generously willing to take part in trials who may have, at the back of their mind, the thought that AVA6k will help them live longer themselves. They must have agreed for samples to be taken in due course in order to get onto the trial.
If AVA6k did happen to work very well – extraordinarily well – even with the people on the trial, then the very success of the drug would inevitably delay the actual news arrival. (What better reason could there be for late news.)
Is that about it? I'm sure this will have been discussed but I've forgotten the answer.